Protalix BioTherapeutics PLX
NYSE PLX
$3.13 +0.28 (+9.62%)
As of: Nov 11, 2026 · 3:59 PM EST

Protalix BioTherapeutics (PLX) Notes Payables (2019 - 2020)

Updated

Protalix BioTherapeutics' Notes Payables was $4.09 million in Q4 2020, down 5.0% from $4.3 million a year earlier and down 5.0% from the prior quarter.

Analysis

Protalix BioTherapeutics (PLX) Notes Payables (2019 - 2020) Analysis & Trends

From Q4 2019 onward, Protalix BioTherapeutics has reported Notes Payables for 5 quarters.

  • In earlier years, Notes Payables was $4.3 million in FY2019.
  • Per Business Quant data, PLX's Notes Payables in the three quarters before Q4 2020 was $4.3 million (Q3 2020), $4.3 million (Q2 2020) and $4.3 million (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Protalix BioTherapeutics 230.43 Mn 59.88 Mn 14.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 4.09 Mn
Sep 30, 2020 4.30 Mn
Jun 30, 2020 4.30 Mn
Mar 31, 2020 4.30 Mn
Dec 31, 2019 4.30 Mn
API Access

Protalix BioTherapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=PLX&period=max&api_key=YOUR_API_KEY